These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6798720)

  • 21. Spotlight on the continual applicability of routine plasma monitoring antiepileptic drugs in the treatment of epilepsy.
    El Desoky E; Kandil MR; Afifi AH; Mostafa OA
    Pharmacol Res; 1999 Apr; 39(4):269-74. PubMed ID: 10208756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interactions of serum albumin, valproic acid and carbamazepine with the pharmacokinetics of phenytoin in cancer patients.
    Joerger M; Huitema AD; Boogerd W; van der Sande JJ; Schellens JH; Beijnen JH
    Basic Clin Pharmacol Toxicol; 2006 Aug; 99(2):133-40. PubMed ID: 16918714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Color vision tests for early detection of antiepileptic drug toxicity.
    Bayer AU; Thiel HJ; Zrenner E; Dichgans J; Kuehn M; Paulus W; Ried S; Schmidt D
    Neurology; 1997 May; 48(5):1394-7. PubMed ID: 9153479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of single doses of sodium valproate on serum phenytoin levels and protein binding in epileptic patients.
    Monks A; Richens A
    Clin Pharmacol Ther; 1980 Jan; 27(1):89-95. PubMed ID: 6985856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variability of phenytoin, carbamazepine and valproate concentrations in a clinic population.
    Leppik IE
    Epilepsy Res Suppl; 1988; 1():85-90. PubMed ID: 3149581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of total and free anticonvulsant serum levels in clinical practice.
    Beran RG; Lewis JH; Nolte JL; Westwood AP
    Clin Exp Neurol; 1985; 21():69-77. PubMed ID: 3939613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Valproic acid in epilepsy: clinical and pharmacological effects.
    Mattson RH; Cramer JA; Williamson PD; Novelly RA
    Ann Neurol; 1978 Jan; 3(1):20-5. PubMed ID: 350128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Daily plasma fluctuations of diphenylhydantoin in patients treated with diphenylhydantoin and sodium valproate].
    Pisani F; Di Perri R
    Acta Neurol Quad (Napoli); 1981; 42():61-3. PubMed ID: 6791452
    [No Abstract]   [Full Text] [Related]  

  • 29. Unbound plasma phenytoin concentrations measured using enzyme immunoassay technique on the cobas MIRA analyser--in vivo effect of valproic acid.
    Sallustio BC; Morris RG
    Ther Drug Monit; 1992 Feb; 14(1):9-13. PubMed ID: 1546396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma protein binding interaction between phenytoin and valproic acid in vitro.
    Monks A; Boobis S; Wadsworth J; Richens A
    Br J Clin Pharmacol; 1978 Dec; 6(6):487-92. PubMed ID: 365209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Valproic acid and phenytoin effects on serum proteins and immunoglobulins of epileptic patients.
    Garzón P; González-Cornejo S; Román-Maldonado S; Navarro-Ruiz A
    Gen Pharmacol; 1985; 16(4):411-3. PubMed ID: 2412936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of heating human sera at a temperature necessary to deactivate human immunodeficiency virus on measurement of free phenytoin, free valproic acid, and free carbamazepine concentrations.
    Dasgupta A; Wells A; Chow L
    Ther Drug Monit; 1999 Aug; 21(4):421-5. PubMed ID: 10442696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Measurement of the blood concentration of antiepileptic drugs. II Special cases].
    Loiseau P; Brachet A; Henry P
    Nouv Presse Med; 1975 May; 4(21):1573-6. PubMed ID: 765962
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of sodium valproate and phenytoin as single drug treatment in generalised and partial epilepsy.
    Rastogi P; Mehrotra TN; Agarwala RK; Singh VS
    J Assoc Physicians India; 1991 Aug; 39(8):606-8. PubMed ID: 1814875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Valproic acid in the treatment of epilepsy with special emphasis on serum level determination (author's transl)].
    Fröscher W; Schulz HU; Gugler R
    Fortschr Neurol Psychiatr Grenzgeb; 1978 Jun; 46(6):327-41. PubMed ID: 352872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Anticonvulsive combined therapy (author's transl)].
    Deisenhammer E; Sommer R; Nitsche V
    Wien Klin Wochenschr; 1980 Jan; 92(1):23-4. PubMed ID: 6769255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Daily fluctuations of plasma diphenylhydantoin in patients treated with diphenylhydantoin and sodium valproate].
    Pisani F; Di Perri R
    Acta Neurol (Napoli); 1981 Feb; 3(1):61-3. PubMed ID: 6787844
    [No Abstract]   [Full Text] [Related]  

  • 38. Are serum anticonvulsant levels in people with epilepsy appropriately monitored?
    Thapar A; Richens A; Roland M; Jacoby A; Russell I; Roberts C; Porter E; Wall S
    J Eval Clin Pract; 2001 Aug; 7(3):335-8. PubMed ID: 11555091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum bilirubin levels with antiepileptic drugs.
    Gough H; Goggin T; Crowley M; Callaghan N
    Epilepsia; 1989; 30(5):597-602. PubMed ID: 2507305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The newer antiepileptic drugs: carbamazepine and valproic acid.
    Mikati M
    Pediatr Ann; 1991 Jan; 20(1):34-40. PubMed ID: 2000232
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.